NCT03693586View on ClinicalTrials.gov

Study to Determine the Hepatitis C Virus Infection Prevalence Among Patients Attended Primarily for Vasculitis

CompletedOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

October 19, 2018

Primary Completion Date

March 8, 2022

Study Completion Date

March 8, 2022

Conditions
Chronic Hepatitis cVasculitis
Trial Locations (1)

06726

Hospital General de Mexico, Mexico City

Sponsors

Collaborators (1)

AbbVie
All Listed Sponsors
collaborator

AbbVie

INDUSTRY

lead

Hospital General de Mexico

OTHER_GOV